This trend is further supported by Figure 3(b), which demonstrates that higher LSM1 expression is associated with a significant decrease in disease-specific survival, emphasizing the impact of LSM1 on glioma-specific mortality. The gene discussed is LSM1; the disease is central nervous system cancer.